参考文献/References:
[1]胡付品,郭燕,朱德妹,等.2016年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2017,17(5):481-491.
[2]赵虎,孔宪涛.AmpC β内酰胺酶的检测[J].中华检验医学杂志,2003,26(6): 390-392.
[3]王新慧,许可欣.产AmpC 酶大肠埃希菌的检测及耐药分析[J].国际检验医学杂志,2016,37(8):1112-1114.
[4]Younas S,Ejaz H,Zafar A,et al.AmpC beta-lactamases in Klebsiella pneumoniae:An emerging threat to the paediatric patients[J].Park Med Assoc,2018,68(6):893-897.
[5]Markovska R,Schneider I,Marteva-Proevsk Y,et al.First detection of the AmpC beta-lactamase ACC-1 in a Klebsiella pneumoniae isolate in Bulgaria[J].Chemother,2012,24(5):307-308.
[6]王晓丽,葛亮,李兴华.产超广谱β-内酰胺酶和头孢菌素酶肺炎克雷伯菌的分布及耐药特征分析[J].中华医院感染学杂志,2018,28(1):5-9.
[7]张戡,邓敏,谢新,等.产AmpC肺炎克雷伯菌质粒介导的多药耐药性与基因型研究[J].中华医院感染学杂志,2016,26(1):7-9.
[8]Liu XQ,Liu YR.Detection and genotype analysis of AmpC β-lactamase in Klebsiella pneumoniae from tertiary hospitals[J].Exp Ther Med,2016,12(1):480-484.
[9]郑港森,刘赞赞,张加勤,等.大肠埃希菌和肺炎克雷伯菌质粒型AmpC酶基因型的检测分析[J].国际检验医学杂志,2015, 36(11):1505-1506.
相似文献/References:
[1]杜 佳.2018年~2019年杭州某医院肺炎克雷伯菌耐药性分析[J].医学信息,2021,34(10):153.[doi:10.3969/j.issn.1006-1959.2021.10.044]
DU Jia.Analysis of the Resistance of Klebsiella Pneumoniae in a Hospital in Hangzhou from 2018 to 2019[J].Journal of Medical Information,2021,34(19):153.[doi:10.3969/j.issn.1006-1959.2021.10.044]
[2]陆 颖,朱志军,朱 梅.肺炎克雷伯菌的耐药性及其与生物膜形成的关系[J].医学信息,2021,34(13):65.[doi:10.3969/j.issn.1006-1959.2021.13.017]
LU Ying,ZHU Zhi-jun,ZHU Mei.Drug Resistance of Klebsiella Pneumoniae and Its Relationship with Biofilm Formation[J].Journal of Medical Information,2021,34(19):65.[doi:10.3969/j.issn.1006-1959.2021.13.017]
[3]周晓玲,张嘉文,陈惠霞.2018-2020年某三甲医院肺炎克雷伯菌的分布情况及耐药现状分析[J].医学信息,2022,35(20):114.[doi:10.3969/j.issn.1006-1959.2022.20.030]
ZHOU Xiao-ling,ZHANG Jia-wen,CHEN Hui-xia.Analysis of Distribution and Drug Resistance of Klebsiella Pneumoniae in A Tertiary Hospital from 2018 to 2020[J].Journal of Medical Information,2022,35(19):114.[doi:10.3969/j.issn.1006-1959.2022.20.030]